Company: APM
Filing Date: 2025-07-15
Form Type: DRS
Source: 0001213900-25-063906
Chunk: 184

Company: Aptorum Group Ltd
Filing Date: 2025-07-15
Form: DRS
Chunk 184
---
 who, being present in person or by proxy and entitled to vote at the Special Meeting, vote at the Special Meeting. Abstentions and broker non -votes, while considered present for the purposes of establishing a quorum, will not count as votes cast at the Special Meeting. Resolution to be Voted Upon “ RESOLVED, as an ordinary resolution, that the adjournment of the Special Meeting to a later date or dates, if necessary: (1) to permit further solicitation and vote of proxies in the event that there are insufficient votes for the approval of one or more proposals at the Special Meeting; (2) for the absence of a quorum; (3) to allow reasonable additional time for the filing or mailing of any supplemental or amended disclosure that Aptorum has determined in good faith after consultation with outside legal counsel is required under applicable law and for such supplemental or amended disclosure to be disseminated and reviewed by its shareholders prior to the Special Meeting; or (4) in order to engage with investors, be approved.” Recommendation of the Aptorum Board THE APTORUM BOARD UNANIMOUSLY RECOMMENDS THAT APTORUM SHAREHOLDERS VOTE “FOR” THE APPROVAL OF THE ADJOURNMENT PROPOSAL. 93 THE MERGER This section describes the Merger and the related transactions. The description in this section and elsewhere in this proxy statement/prospectus is qualified in its entirety by reference to the complete text of the Merger Agreement, a copy of which is attached as Annex [] and is incorporated by reference into this proxy statement/prospectus. This summary does not purport to be complete and may not contain all of the information about the Merger and the related transactions that is important to you. You are encouraged to read the Merger Agreement carefully and in its entirety. This section is not intended to provide you with any factual information about Aptorum or DiamiR. Such information can be found elsewhere in this proxy statement/prospectus and in the public filings Aptorum makes with the SEC that are incorporated by reference herein, as described in the section of this proxy statement/prospectus entitled “Where You Can Find More Information.” Background of the Merger The following chronology is a summary description of the background of the negotiations and the proposed merger and does not purport to catalogue every conversation among representatives of Aptorum Group, DiamiR Biosciences and other parties. The terms of the Merger Agreement are the result of extensive arm’ s -length negotiations